September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 25, 2025

Mediterranean Diet Cut Psoriasis Severity Over 16 Weeks

Dietitian-guided Mediterranean diet increases adherence and improves patient-reported psoriasis measures.

Conexiant

September 25, 2025

GLP-1 RAs Show Lower Risks in Psoriasis

GLP-1 RAs use in psoriasis is associated with lower alcohol and substance abuse risks.

Conexiant

September 18, 2025

Psoriasis Linked to Macular Degeneration

 Vision-threatening eye disease more common in psoriasis patients, but biologic therapy appears protective.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

April 30, 2024

Novel Gene Variants May Be Predisposing Factor for Generalized Pustular Psoriasis

Researchers may have uncovered genetic factors linked to the development of generalized pustular psoriasis.

Conexiant

November 26, 2024

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

A recent study reveals significant treatment response improvements in severe psoriatic arthritis and extensive psoriasis, emphasizing the need for personalized treatment strategies and sensitive outcome measures. (Source: Psoriatic Arthritis Research Consortium)

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant